Clinical Trial Update: Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing pegylated interferon plus ribavirin in subjects of First Nations, Metis, and Caucasian ethnicity for chronic hepatitis C has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: University of Manitoba | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED